Bone marrow stromal cell therapy improves femoral bone mineral density and mechanical strength in ovariectomized rats

References

• Melton LJ, Atkinson EJ, O'Fallon WM, et al. Long-term fracture risk prediction with bone mineral measurements made at various skeletal sites. J Bone Miner Res 1993; 8: 1227–33
   PubMed Web of Science ®Google Scholar
• Terasaki S. Educational Activities About Osteoporosis in Japan. 2005. http://www.jpof.or.jp/content/pdf/text.pdf.
   Google Scholar
• Empana JP, Dargent-Molina P, Breart G. EPIDOS Group. Effect of hip fracture on mortality in elderly women: the EPIDOS prospective study. J Am Geriatr Soc 2004; 52: 685–90
   PubMed Web of Science ®Google Scholar
• Fujisawa S. Epidemiology of osteoporosis. Clin Calcium 2005; 15: 577–82
   PubMedGoogle Scholar
• Lill CA, Gerlach UV, Eckhardt C, et al. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos Int 2002; 13: 407–14
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Bianco P, Robey PG. Marrow stromal stem cells. J Clin Invest 2000; 105: 1663–8
   PubMed Web of Science ®Google Scholar
• Muragliaa A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000; 113: 1161–6
   PubMed Web of Science ®Google Scholar
• Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19: 180–92
   PubMed Web of Science ®Google Scholar
• Tsuchida H, Hashimoto J, Crawford E, et al. Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Ortho Res 2003; 21: 44–53
   PubMed Web of Science ®Google Scholar
• Wang Z, Goh J, Shamal Das DE, et al. Efficacy of bone marrow-devided stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng 2006; 12: 1753–61
   PubMedGoogle Scholar
• Bruder SP, Jaiswal N, Ricalton NS, et al. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop 1998; 355S: S247–56
   Google Scholar
• Mastrogiacomo M, Muraglia A, Komlev V, et al. Tissue engineering of bone: search for a better scaffold. Orthod Craniofac Res 2005; 8: 227–84
   Google Scholar
• Yamada Y, Boo JS, Ozawa R, et al. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. J Craniomaxillofac Surg 2003; 31: 27–33
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 262–4
   PubMed Web of Science ®Google Scholar
• Cancedda R, Dozin B, Giannoni P, Quarto R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 2003; 22: 81–91
   PubMed Web of Science ®Google Scholar
• Krebsbach PH, Kuznetsov SA, Satomura K, et al. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997; 63: 1059–69
   PubMed Web of Science ®Google Scholar
• Arinzeh TL, Peter SJ, Archambault MP, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003; 85-A: 1927–35
   PubMed Web of Science ®Google Scholar
• Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344: 385–6
   PubMed Web of Science ®Google Scholar
• Wronski TJ, Schenck PA, Cintron M, Walsh CC. Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int 1987; 40: 155–9
   PubMed Web of Science ®Google Scholar
• Akhter MP, Wells DJ, Short SJ, et al. Bone biomechanical properties in LRP5 mutant mice. Bone 2004; 35: 162–9
   PubMed Web of Science ®Google Scholar
• Cummings SR, Karpf DB, Harris F, et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002; 112: 281–9
   PubMed Web of Science ®Google Scholar
• Watts NB, Cooper C, Lindsay R, et al. Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate. J Clin Densitom 2004; 7: 256–61
   Web of Science ®Google Scholar
• Li Z, Meredith MP, Hoseyni MS. A method to assess the proportion of treatment effect explained by surrogate endpoint. Stat Med 2001; 20: 3175–88
   PubMed Web of Science ®Google Scholar
• Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone 1993; 14: 595–608
   PubMed Web of Science ®Google Scholar
• Hughes DE, Dai A, Tiffee JC, et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-(. Nat Med 1996; 2: 1132–6
   PubMed Web of Science ®Google Scholar
• Janssens K, ten Dijke P, Janssens S, Van Hul W. Transforming growth factor beta1 to the bone. Endocr Rev 2005; 16: 743–74
   Google Scholar
• Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell 2006; 125: 247–60
   PubMed Web of Science ®Google Scholar
• Ruggiero SL, Mebrotra B, Rosenberg TJ, Engroff SL. Osteoporosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004; 62: 527–34
   PubMed Web of Science ®Google Scholar
• Dannemann C, Gratz KW, Riener MO, Zwahlen RA. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Bone 2007; 40: 828–34
   PubMed Web of Science ®Google Scholar
• Dimitrakopoulos I, Magopoulos C, Karakasis D. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. Int J Oral Maxillofac Surg 2006; 35: 588–93
   PubMed Web of Science ®Google Scholar